Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ACTR10	"ACTR11, Arp10, Arp11, HARP11"	ENSG00000131966	"Actin related protein 10"	Q9NZ32	14	58200080-58235636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"Bile duct cancer: 53.7"	"Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000699			Approved	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 46: Non-specific - Unknown function"	"Cluster 18: Non-specific - Mixed function"	"Vesicles, Plasma membrane, Focal adhesion sites"		"HPA000699: "	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.61e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (3.20e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.48e-8)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.48e-2)"
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.5;Extravillous trophoblasts: 134.6;Inhibitory neurons: 114.5;Late spermatids: 378.0;Oligodendrocyte precursor cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;T-cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Adipose progenitor cells, Heart muscle - Fibroblasts, Skin - Endothelial cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 37: Neurons - Neuronal signaling"	"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 66: Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788609-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 168.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Stomach - Gastric mucous cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: Non-specific - Unknown function"	"Cluster 36: Spermatids - Spermatogenesis"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 46: Granulocytes - Mast cell degranulation"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 708.6;Alveolar cells type 2: 887.1;Endometrial stromal cells: 925.9;Fibroblasts: 553.4;Granulosa cells: 913.5;Smooth muscle cells: 1776.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"Neuroblastoma: 49.7"	"Adipose subcutaneous - Smooth muscle cells, Colon - Neutrophils"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 72: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 641.3;tongue: 470.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 306.5;Early spermatids: 363.3;Excitatory neurons: 240.6;Late spermatids: 750.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 68: Kidney - Mixed function"	"Cluster 36: Spermatids - Spermatogenesis"	"Nucleoplasm, Focal adhesion sites"	Cytosol	"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002921-75012366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 198.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		12000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 46: Non-specific - Unknown function"	"Cluster 67: Syncytiotrophoblasts - Pregnancy"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Colon - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		15000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365253-31376850	"Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 652.4;Cardiomyocytes: 2566.2;Distal tubular cells: 478.9;Proximal tubular cells: 899.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Kupffer cells, Prostate - Smooth muscle cells, Testis - Leydig cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	3000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 30: Breast - Lactation"	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 139.7;Exocrine glandular cells: 124.3;Extravillous trophoblasts: 132.0;Gastric mucus-secreting cells: 127.6;Peritubular cells: 182.6;Proximal enterocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Lung - Smooth muscle cells, Skin - Outer root sheath cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 183.1;Extravillous trophoblasts: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Colon - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.6;Oligodendrocytes: 154.2;Schwann cells: 262.9"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cancer enriched"	"Detected in many"	5	"skin cancer: 129.1"	"Breast - Fibroblasts, Colon - Enteric glia cells, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts, Skin - Keratinocyte (granular), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 33: Skin cancer - Membrane components"	"Cluster 65: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.4;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Lung - Endothelial cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 66: Endothelial cells - Angiogenesis"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.5;Gastric mucus-secreting cells: 39.9;NK-cells: 140.1;Plasma cells: 110.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 50.3;lymphoma: 32.9;Myeloma: 30.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 40: Plasma cells - Humoral immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 159.6;Endothelial cells: 115.0;granulocytes: 625.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Cancer enhanced"	"Detected in many"		"Esophageal cancer: 23.2"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 46: Granulocytes - Mast cell degranulation"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Smooth muscle cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Myogenesis"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 92.1;Inhibitory neurons: 119.4;Microglial cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 32: Neurons - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 597.8;Proximal enterocytes: 281.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		9400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 6: Late spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 2096.7"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Thyroid - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 77: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 118.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.2;Langerhans cells: 208.8;Macrophages: 82.0;Plasma cells: 72.7;T-cells: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"lymphoma: 157.1"	"Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586129	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.9;monocytes: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 2: T-cells - T-cell receptor"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99646113-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 130.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 470.8;Cardiomyocytes: 255.3;Endothelial cells: 206.7;Mucus glandular cells: 129.8;Skeletal myocytes: 177.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 27.7"	"Colon - Endothelial cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 47: Retina - Visual perception"	"Cluster 66: Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"	Q9NVD7	11	12377563-12535356	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast), Colon - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		7300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Group enriched"	"Detected in all"	5	"Cardiomyocytes: 2678.8;Skeletal myocytes: 869.0"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Smooth muscle cells, Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 77: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 74: Pancreatic cells - Mixed function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 81.1;Peritubular cells: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Smooth muscle cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 46: Non-specific - Unknown function"	"Cluster 31: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 285.9;Excitatory neurons: 576.3;Inhibitory neurons: 257.5;Oligodendrocyte precursor cells: 338.9;Oligodendrocytes: 747.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	Yes		25000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 38: Neurons - Neuronal signaling"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.6"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 66: Endothelial cells - Angiogenesis"	"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439435-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 582.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"		NA	NA		340000	"Cluster 6: Non-specific - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 58: Non-specific - Basic cellular processes"	"Cluster 77: Cardiomyocytes - Muscle contraction"	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (6.70e-4)"
RTN4R	NOGOR	ENSG00000040608	"Reticulon 4 receptor"	Q9BZR6	22	20241415-20283246	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;liver: 12.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.0;Excitatory neurons: 14.0;Muller glia cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 8.0;basal ganglia: 20.0;cerebellum: 20.9;cerebral cortex: 24.3;hippocampal formation: 12.7"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.8"	"Lineage enriched"	"Detected in many"	9	"T-cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012443			Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		1900000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 14: Bone cancer - Transcription"	"Cluster 38: Neurons - Neuronal signaling"	"Plasma membrane, Focal adhesion sites"	"Actin filaments"	"CAB012443: "	"unprognostic (1.28e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.07e-1)"
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 112.3;Hofbauer cells: 65.6;Langerhans cells: 53.8;Oligodendrocyte precursor cells: 128.0;Schwann cells: 90.9;Sertoli cells: 74.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 44.9"	"Kidney - Proximal tubular cells, Testis - Sertoli cells"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 121.3;Oligodendrocytes: 437.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 4.5;testis cancer: 3.6"	"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Thyroid - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 8: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 477.4;Rod photoreceptor cells: 712.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 44: Photoreceptor cells - Visual perception"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 775.3;Cardiomyocytes: 744.8;Excitatory neurons: 395.4;Inhibitory neurons: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.1"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Colon - Smooth muscle cells, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Thyroid - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Rabdoid cancer - Embryonic development"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"
TATDN3		ENSG00000203705	"TatD DNase domain containing 3"	Q17R31	1	212791828-212816830	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032092	Approved		Approved	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: Non-specific - RNA binding"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Focal adhesion sites"	"HPA032092: AB_10671086"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.34e-3)"	"unprognostic (5.02e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.96e-3)"
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 97.9;Endometrial stromal cells: 81.4;Leydig cells: 92.9;Pancreatic endocrine cells: 84.2;Peritubular cells: 182.6;Sertoli cells: 102.3;Smooth muscle cells: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Breast - Smooth muscle cells, Colon - Smooth muscle cells, Lung - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020844, HPA072360"	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 15: Smooth muscle cells - Muscle contraction"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB020844: , HPA072360: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"
TMEM35A	"FLJ14084, NACHO, TMEM35, TUF-1"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078879-101096367	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.9;intestine: 36.8;seminal vesicle: 50.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.4;Excitatory neurons: 14.8;Horizontal cells: 16.7;Inhibitory neurons: 24.1;Oligodendrocyte precursor cells: 12.5;Peritubular cells: 20.3;Theca cells: 26.2"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 13.5"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 15: Smooth muscle cells - Muscle contraction"	Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 170.2;Kupffer cells: 114.2;Langerhans cells: 304.0;Macrophages: 156.7;monocytes: 428.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 505.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9"	"Cancer enriched"	"Detected in some"	10	"Leukemia: 22.9"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	790000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 5.2;Alveolar cells type 2: 8.3;Extravillous trophoblasts: 16.9;Horizontal cells: 10.9;Spermatogonia: 14.9"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"testis cancer: 76.3"	"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Testis - Spermatogonia"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 6: BEWO - Unknown function"	"Cluster 54: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867387-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		21000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: Non-specific - Transcription"	"Cluster 18: Non-specific - Mixed function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 509.9;monocytes: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 19: Macrophages - Innate immune response"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 100.9;fallopian tube: 32.7;pancreas: 30.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 59.9;Club cells: 29.8;Collecting duct cells: 45.3;Ductal cells: 76.4;Endometrial ciliated cells: 41.4;Glandular and luminal cells: 80.8;Mucus glandular cells: 63.7;Salivary duct cells: 31.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"breast cancer: 43.8;ovarian cancer: 40.3;testis cancer: 29.9"	"Heart muscle - Cardiomyocytes, Lung - Respiratory ciliated cells, Prostate - Urothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA				"Cluster 5: Breast - Unknown function"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 73: Prostatic glandular cells - Transcription"	"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 204.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 4: Platelets - Platelet activation"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"